Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial.
about
Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Oral liarozole in the treatmen ...... controlled phase II/III trial.
@ast
Oral liarozole in the treatmen ...... controlled phase II/III trial.
@en
Oral liarozole in the treatmen ...... controlled phase II/III trial.
@nl
type
label
Oral liarozole in the treatmen ...... controlled phase II/III trial.
@ast
Oral liarozole in the treatmen ...... controlled phase II/III trial.
@en
Oral liarozole in the treatmen ...... controlled phase II/III trial.
@nl
prefLabel
Oral liarozole in the treatmen ...... controlled phase II/III trial.
@ast
Oral liarozole in the treatmen ...... controlled phase II/III trial.
@en
Oral liarozole in the treatmen ...... controlled phase II/III trial.
@nl
P2093
P2860
P921
P356
P1476
Oral liarozole in the treatmen ...... controlled phase II/III trial.
@en
P2093
A Vahlquist
K van Rossem
P Steijlen
S Blockhuys
P2860
P304
P356
10.1111/BJD.12626
P407
P577
2014-01-01T00:00:00Z